Alternative Treatments for Apprehensive DED PatientsNovember 20, 2023 With patient apprehension from OTC eye drop recalls, James Deom, OD, leads with education first, followed by safe and proven in-office treatments. Read Full Article Explore Other Resources Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubRevolutionizing Dry Eye TreatmentDry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubLumenis’s OptiPLUS Delivers Clinically Significant Results for DEDBlog PostsDry EyeTreatment TypeVision Resource HubBlog PostsDry EyeTreatment TypeVision Resource HubEnhance Patient Care with the Sequential Use of OptiPLUS & OptiLIGHT LEARN HOW YOU CAN ELEVATE YOUR PRACTICE DOWNLOAD OPTILIGHT INFO KIT Learn about the first and only IPL FDA approved for dry eye management PB-00043680 Rev C
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubRevolutionizing Dry Eye Treatment
Dry EyePress PublicationsVision Resource HubDry EyePress PublicationsVision Resource HubLumenis’s OptiPLUS Delivers Clinically Significant Results for DED
Blog PostsDry EyeTreatment TypeVision Resource HubBlog PostsDry EyeTreatment TypeVision Resource HubEnhance Patient Care with the Sequential Use of OptiPLUS & OptiLIGHT